HOOK — Hookipa Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $77.39m
- -$14.22m
- $20.13m
- 35
- 50
- 86
- 58
Annual cashflow statement for Hookipa Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -43 | -44.1 | -75.7 | -64.9 | -81.6 |
| Depreciation | |||||
| Non-Cash Items | 7.24 | 8.71 | 8.87 | 5.2 | 15.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7.38 | -8.12 | -3.86 | 36.1 | 5.33 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -41.7 | -39.3 | -66 | -20 | -57.5 |
| Capital Expenditures | -2 | -2.37 | -12.6 | -5.02 | -4.16 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -2 | -2.37 | -12.6 | -5.02 | -4.16 |
| Financing Cash Flow Items | — | -0.224 | 0 | -0.195 | -0.149 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 110 | 73.4 | -0.235 | 72.3 | 65.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 65 | 29.6 | -76.3 | 46.5 | 4.08 |